PRELUDE CAPITAL MANAGEMENT, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 30 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2017$2,000
-60.0%
2,000
-81.0%
0.00%
-100.0%
Q4 2016$5,00010,500
+10400.0%
0.00%
Q2 2016$01000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Zhang Financial LLC 45,000$36,0000.02%
A.R.T. Advisors, LLC 381,955$319,0000.02%
Virtu KCG Holdings LLC 705,907$591,0000.02%
OXFORD ASSET MANAGEMENT LLP 687,796$576,0000.01%
ETF MANAGERS GROUP, LLC 89,813$73,0000.01%
FEDERATED HERMES, INC. 1,945,682$1,630,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 324,479$272,000,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$253,0000.00%
WEDBUSH SECURITIES INC 23,000$19,0000.00%
Renaissance Technologies 2,300,800$1,927,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders